BRPI0920982A8 - Vírus da diarreia viral bovina com uma proteína erns. - Google Patents

Vírus da diarreia viral bovina com uma proteína erns.

Info

Publication number
BRPI0920982A8
BRPI0920982A8 BRPI0920982A BRPI0920982A BRPI0920982A8 BR PI0920982 A8 BRPI0920982 A8 BR PI0920982A8 BR PI0920982 A BRPI0920982 A BR PI0920982A BR PI0920982 A BRPI0920982 A BR PI0920982A BR PI0920982 A8 BRPI0920982 A8 BR PI0920982A8
Authority
BR
Brazil
Prior art keywords
diarrhea virus
bovine viral
viral diarrhea
protein
chimeric
Prior art date
Application number
BRPI0920982A
Other languages
English (en)
Inventor
Gerard Ankenbauer Robert
Luo Yugang
Wan Welch Siao-Kun
Yuan Ying
Original Assignee
Zoetis Services Llc
Pfizer
Ah Usa 42 Llc
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41665513&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0920982(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc, Pfizer, Ah Usa 42 Llc, Zoetis Llc filed Critical Zoetis Services Llc
Publication of BRPI0920982A2 publication Critical patent/BRPI0920982A2/pt
Publication of BRPI0920982A8 publication Critical patent/BRPI0920982A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Abstract

USO DE PESTIVÍRUS QUIMÉRICOS EM COMPOSIÇÕES IMUNOGÊNICAS E VACINAS. A presente invenção refere-se a pestivírus quiméricos tendo utilidade como composições imunogênicas em que o referido pestivírus quiméricos compreende um vírus de diarreia viral boviva que não expressa sua proteína E ms homóloga, também em que o referido pestevírus quimérico expressa uma proteína E ms heteróloga derivada de outros pestevírus ou uma variante natural, sintética ou genética da referida protéina E ms heteróloga. Da mesma forma dão descritos aqui métodos e kits para tratar ou prevenir a expansão de infecção por vírus da diarreia viral bovina, bem como métodos e kits para diferenciação entre animais vacinados e infectados tipo selvagem
BRPI0920982A 2008-12-03 2009-11-23 Vírus da diarreia viral bovina com uma proteína erns. BRPI0920982A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11959408P 2008-12-03 2008-12-03
US17336309P 2009-04-28 2009-04-28
PCT/IB2009/055291 WO2010064164A1 (en) 2008-12-03 2009-11-23 Bovine viral diarrhea virus with a modified erns protein

Publications (2)

Publication Number Publication Date
BRPI0920982A2 BRPI0920982A2 (pt) 2016-10-04
BRPI0920982A8 true BRPI0920982A8 (pt) 2017-09-19

Family

ID=41665513

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920982A BRPI0920982A8 (pt) 2008-12-03 2009-11-23 Vírus da diarreia viral bovina com uma proteína erns.

Country Status (20)

Country Link
US (2) US9567375B2 (pt)
EP (1) EP2373785B1 (pt)
JP (1) JP5744748B2 (pt)
KR (1) KR101453146B1 (pt)
CN (1) CN102239251B (pt)
AR (1) AR075484A1 (pt)
AU (1) AU2009323784B2 (pt)
BR (1) BRPI0920982A8 (pt)
CA (1) CA2744750C (pt)
CL (1) CL2011001343A1 (pt)
CO (1) CO6440541A2 (pt)
ES (1) ES2681685T3 (pt)
ME (1) ME01140B (pt)
MX (1) MX2011005820A (pt)
NZ (1) NZ592979A (pt)
RU (2) RU2524426C2 (pt)
TW (1) TWI485248B (pt)
UY (1) UY32274A (pt)
WO (1) WO2010064164A1 (pt)
ZA (1) ZA201104508B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2811243C (en) * 2010-09-21 2019-03-05 Intervet International B.V. Bvdv vaccine
JP6080850B2 (ja) * 2011-08-24 2017-02-15 ゾエティス・サービシーズ・エルエルシー 改善されたワクチン診断法
BR112017012484B1 (pt) * 2014-12-19 2024-02-06 Intervet International B.V Vacina para combater tremor congênito (ct) do grupo a-ii em porcos
MX2018008085A (es) * 2015-12-30 2018-08-23 Intervet Int Bv Vacuna marcadora contra pestivirus.
DE102018110208A1 (de) * 2018-04-27 2019-10-31 Stiftung Tierärztliche Hochschule Hannover Gentechnisch veränderte Pestiviren und deren Verwendung als Markerimpfstoff
GB201910730D0 (en) * 2019-07-26 2019-09-11 Randox Teoranta Bovine Pathogen Array
CN111057132B (zh) * 2019-10-16 2022-01-07 四川农业大学 牛病毒性腹泻病毒e0蛋白氨基酸及制备方法
CN110665002B (zh) * 2019-10-29 2023-01-24 信阳市动物疫病预防控制中心 一种用于防治牛病毒性腹泻的抗体制剂及其制备方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112961224B (zh) * 2021-03-26 2022-09-27 中国农业大学 牛病毒性腹泻病毒1型病毒样颗粒的制备及应用
CN114773438B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e0截短蛋白、制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6060457A (en) * 1996-06-20 2000-05-09 Universite De Montreal DNA plasmid vaccine for immunization of animals against BVDV
EP0982402A1 (en) 1998-08-14 2000-03-01 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Pestivirus vaccination
RU2158306C2 (ru) * 1999-01-19 2000-10-27 Институт экспериментальной ветеринарии Сибири и Дальнего Востока СО РАСХН Способ выявления вируса вирусной диареи (болезни слизистых оболочек) крупного рогатого скота с помощью специфических олигонуклеотидных праймеров в полимеразной цепной реакции
EP2365082A1 (en) * 2000-06-27 2011-09-14 Pfizer Animal Health S.A. BVDV virus-like particles
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon
US7361357B2 (en) * 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina

Also Published As

Publication number Publication date
CL2011001343A1 (es) 2012-03-23
ME01140B (me) 2013-03-20
TW201024416A (en) 2010-07-01
AU2009323784B2 (en) 2013-08-15
AR075484A1 (es) 2011-04-06
CA2744750A1 (en) 2010-06-10
RU2011121044A (ru) 2013-01-10
JP2012510285A (ja) 2012-05-10
EP2373785A1 (en) 2011-10-12
WO2010064164A1 (en) 2010-06-10
CN102239251A (zh) 2011-11-09
CA2744750C (en) 2018-10-09
KR20110091579A (ko) 2011-08-11
US20170151321A1 (en) 2017-06-01
CO6440541A2 (es) 2012-05-15
RU2013141044A (ru) 2015-03-20
TWI485248B (zh) 2015-05-21
EP2373785B1 (en) 2018-06-27
US20100136055A1 (en) 2010-06-03
CN102239251B (zh) 2014-04-23
US9567375B2 (en) 2017-02-14
NZ592979A (en) 2012-08-31
JP5744748B2 (ja) 2015-07-08
KR101453146B1 (ko) 2014-10-27
UY32274A (es) 2010-06-30
RU2524426C2 (ru) 2014-07-27
AU2009323784A1 (en) 2010-06-10
MX2011005820A (es) 2011-06-21
ES2681685T3 (es) 2018-09-14
ZA201104508B (en) 2012-11-28
BRPI0920982A2 (pt) 2016-10-04

Similar Documents

Publication Publication Date Title
BRPI0920982A8 (pt) Vírus da diarreia viral bovina com uma proteína erns.
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
AR060565A1 (es) Vacuna para la gripe aviaria y metodos de uso
CL2018001159A1 (es) Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)
BRPI0607551A2 (pt) vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso
BRPI1013780A2 (pt) composições para imunização contra staphylococcus aureus.
EA201600305A1 (ru) Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
PL1951300T3 (pl) Zmiana równowagi TH1/TH2 w szczepionkach typu split przeciwko grypie zawierających adjuwant
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
BR112012019637A2 (pt) método de indução de anticorpos neutralizantes contra quatro sorotipos da febre da dengue, vírus da caxumba, vírus do sarampo e rubéola em um mamífero, kit de imunização e uso de vírus vacinais tetravalentes da dengue e trivalentes de mmr para a fabricação de uma vacina para a imunização
AR094275A1 (es) COMPOSICION INMUNOGENICA QUE COMPRENDE LA PROTEINA CDTb DE CLOSTRIDIUM DIFFICILE
CL2019000019A1 (es) Anticuerpos con baja inmunogenicidad y uso de los mismos
BR112018015453A2 (pt) vírus atenuado da bronquite infecciosa
BR112014004261A2 (pt) diagnósticos de vacina melhorada
CL2021002727A1 (es) Vacuna con subunidades del vfpc
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
MX2016001695A (es) Composiciones inmunogenas de combinacion.
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
NZ721121A (en) Immunogenic compositions and vaccines derived from bacterial surface receptor proteins
BR112012019534A2 (pt) composição, métodos para preparar uma composição, e para selecionar anticorpos, e, kit
BR112014001287A2 (pt) vacina recombinante do vírus da leucemia felina contendo gene otimizado do envelope do vírus da leucemia felina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ZOETIS LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS SERVICES LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B25G Requested change of headquarter approved

Owner name: ZOETIS SERVICES LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]